0000921114-13-000005.txt : 20130710 0000921114-13-000005.hdr.sgml : 20130710 20130709182745 ACCESSION NUMBER: 0000921114-13-000005 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20130710 DATE AS OF CHANGE: 20130709 EFFECTIVENESS DATE: 20130710 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AmpliPhi Biosciences Corp CENTRAL INDEX KEY: 0000921114 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 911549568 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-199282 FILM NUMBER: 13960445 BUSINESS ADDRESS: STREET 1: 800 E. LEIGH STREET STREET 2: SUITE 54 CITY: RICHMOND STATE: VA ZIP: 23219 BUSINESS PHONE: 650-888-2422 MAIL ADDRESS: STREET 1: 800 E. LEIGH STREET STREET 2: SUITE 54 CITY: RICHMOND STATE: VA ZIP: 23219 FORMER COMPANY: FORMER CONFORMED NAME: TARGETED GENETICS CORP /WA/ DATE OF NAME CHANGE: 19940331 D 1 primary_doc.xml X0706 D LIVE 0000921114 AmpliPhi Biosciences Corp 800 E. LEIGH STREET SUITE 54 RICHMOND VA VIRGINIA 23219 650-888-2422 WASHINGTON Xenogen Corporation TARGETED GENETICS CORP /WA/ Corporation true Philip Young 800 E. Leigh Street Suite 54 Richmond VA VIRGINIA 23219 Executive Officer Director Jeremy Curnock Cook 800 E. Leigh Street Suite 54 Richmond VA VIRGINIA 23219 Director Caroline Williams 800 E. Leigh Street Suite 54 Richmond VA VIRGINIA 23219 Director Michael Perry 800 E. Leigh Street Suite 54 Richmond VA VIRGINIA 23219 Director Anthony Smithyman 800 E. Leigh Street Suite 54 Richmond VA VIRGINIA 23219 Director Anthony Gellert 800 E. Leigh Street Suite 54 Richmond VA VIRGINIA 23219 Director Louis Drapeau 800 E. Leigh Street Suite 54 Richmond VA VIRGINIA 23219 Director Kelley Wendt 800 E. Leigh Street Suite 54 Richmond VA VIRGINIA 23219 Executive Officer Biotechnology Decline to Disclose 06 false 2013-06-26 false true true false 0 12490999 12490999 0 false 8 0 0 0 false AmpliPhi Biosciences Corp /s/ Kelley Wendt Kelley Wendt Chief Financial Officer 2013-07-09